Increasing numbers of hypertension cases is bolstering blood pressure monitor market
In a new report from TechNavio, a technology research and advisory company, the global demand for blood pressure monitors will grow at an average rate of 6.53 percent between 2012 and 2016 ― mainly because of the increasing numbers of high and low blood pressure sufferers.
The study, titled the Global Blood Pressure Monitor Market 2012-2016, was based on in-depth analysis covering the Americas, the EMEA (Europe, the Middle East and Africa), and the APAC regions.
According to the World Health Organization’s 2010-2011 Global Status Report on Noncommunicable Diseases, high blood pressure causes around 7.5 million deaths a year worldwide ― about 12.8 percent of all deaths. The incidence of hypertension is similar for all income groups, but generally lowest in the high-income bracket. Between 1980 and 2008 alone, the number of people with hypertension climbed from 600 million to nearly 1 billion. WHO also states that “treating systolic blood pressure and diastolic blood pressure so they are below 140/90 mmHg is associated with a reduction in cardiovascular complications.”
According to TechNavio, the demand for home-use monitors is also being driven by the increased use of Telehealth services ― the delivery of health-related services and information via telecommunications technologies. Monitoring conditions like blood pressure is the most noteworthy use of Telehealth.
An analyst from report’s team explains the global increase in hygiene awareness is also upping the demand for “disposable medical supplies.” Disposable blood pressure monitoring cuffs are increasingly popular because “they reduce the risk of hospital-acquired infections.”
For the same reasons, people might turn to home-use treatments to lower high blood pressure like the portable, computerized RESPeRATE device. RESPeRATE is the first medical device that has been clinically proven to lower blood pressure and without having to take medication or visit a clinic for treatments. RESPeRATE is already used by more than 250,000 men and women worldwide to lower hypertension naturally.
RESPeRATE is the only non-drug therapy cleared by the FDA for the treatment of high blood pressure and the reduction of stress. It is the first medical device that has been clinically proven to lower blood pressure.